Kynos Therapeutics, a spin-out from the University of Edinburgh, is an immunemetabolic company with world-leading expertise in the kynurenine pathway and kynurenine 3monooxygenase (KMO) biology.
VIEW WEBSITE >>
Location: United Kingdom, Scotland, City of Edinburgh
Total raised: $11.76M
Investors 1
| Date | Name | Website |
| - | Epidarex C... | epidarex.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.04.2022 | Seed | $11.76M | Epidarex C... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 06.05.2022 | DIGIT Deal Roundup | April 2022 | Funding SIS Ventures Scottish impact investor SIS Ventures has secured £1m in funding for its Impac... | digit.fyi/... |
| 07.04.2022 | Kynos Therapeutics Raises GBP£9M in Funding | Kynos Therapeutics, an Edinburgh, Scotland, UK-based immune-metabolic company, raised GBP£9M in fund... | finsmes.co... |